How Safe Are Intravitreal Injections? A Closer Look at Side Effects and Outcomes

If you have been told you need regular eye injections to treat wet macular degeneration, diabetic retinopathy, or retinal vein occlusion, the idea can feel overwhelming. The thought of a needle near the eye understandably triggers anxiety. However, intravitreal injections are among the most common procedures in ophthalmology, performed millions of times each year, with a strong safety record and sight-saving outcomes. Understanding the process, the risks, and what most patients actually experience can help ease fear and build confidence in treatment.

Intravitreal injections deliver medication directly into the vitreous cavity of the eye, enabling anti-VEGF agents to reach diseased retinal tissue at therapeutic concentrations. The procedure itself takes only seconds. After numbing drops and sometimes a mild anesthetic gel, the injection is performed with a very fine needle. Most patients report feeling pressure or mild discomfort rather than pain. The entire visit, including preparation and post-injection checks, typically lasts under 30 minutes.

Serious complications are rare. The risk of infection, called endophthalmitis, is the most feared complication but occurs in fewer than 1 in 2,000 injections when proper sterile technique is used. Retinal detachment and significant intraocular bleeding are even less common. The overwhelming majority of injections are uneventful, and patients leave with stable or improved vision.

Minor side effects are more common but temporary. A subconjunctival hemorrhage, or small red spot on the white of the eye, occurs in about 10 to 15 percent of injections. It looks alarming but is harmless and resolves within a week or two. Floaters, particularly a dark spot that moves with eye movement, can appear immediately after injection and typically fade within days as the medication disperses. Some patients notice a scratchy or gritty feeling for a few hours, which responds well to lubricating drops.

Vision may be temporarily blurry immediately after the injection due to the medication, air bubbles, or ointment used during the procedure. This usually clears within hours. Patients are advised to avoid strenuous activity and swimming for a day or two and to watch for warning signs such as severe pain, sudden vision loss, or increasing redness, which may indicate a rare complication requiring urgent attention.

What patients often do not expect is that the process becomes increasingly manageable over time. Many report that the anticipation is worse than the actual injection, and after the first few treatments, anxiety decreases significantly. The trade-off becomes clear: a few seconds of discomfort in exchange for preserving sight and preventing irreversible vision loss.

Real-world data support the effectiveness and safety of ongoing injection therapy. Studies show that consistent treatment can stabilize vision in most patients and improve it in many, particularly when started early. Stopping injections prematurely often leads to disease progression and vision decline.

For questions about intravitreal injections or to discuss your treatment plan, schedule a consultation with Associated Retina Consultants at 602-242-4928 or visit WEBSITE.